These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34867983)

  • 1. Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients.
    Ahn R; Schaenman J; Qian Z; Pickering H; Groysberg V; Rossetti M; Llamas M; Hoffmann A; Gjertson D; Deng M; Bunnapradist S; Reed EF;
    Front Immunol; 2021; 12():750659. PubMed ID: 34867983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma proteome perturbation for CMV DNAemia in kidney transplantation.
    Sigdel TK; Boada P; Kerwin M; Rashmi P; Gjertson D; Rossetti M; Sur S; Munar D; Cimino J; Ahn R; Pickering H; Sen S; Parmar R; Fatou B; Steen H; Schaenman J; Bunnapradist S; Reed EF; Sarwal MM;
    PLoS One; 2023; 18(5):e0285870. PubMed ID: 37205661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
    Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
    Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?
    Fernández-García OA; Hernandez C; Robbins M; Kabbani D; Doucette K; Cervera C
    Transpl Infect Dis; 2024 Aug; 26(4):e14292. PubMed ID: 38728099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Vinuesa V; Bracho MA; Albert E; Solano C; Torres-Puente M; Giménez E; González-Candelas F; Navarro D
    J Gen Virol; 2017 Oct; 98(10):2530-2542. PubMed ID: 28874227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Tasso+ blood self-collection device for quantitation of plasma cytomegalovirus (CMV) DNAemia in adult solid organ transplant recipients (SOTr).
    Phan T; Kumar L; Woo M; Sadowska-Klasa A; Castor J; Pepper G; Fisher CE; Limaye AP
    Microbiol Spectr; 2024 Jul; 12(7):e0003024. PubMed ID: 38771037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients.
    Schaenman J; Phonphok K; Spanuchart I; Duong T; Sievers TM; Lum E; Reed EF; Bunnapradist S
    Transpl Infect Dis; 2021 Feb; 23(1):e13457. PubMed ID: 32892447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients.
    Shapira G; Volkov H; Fabian I; Mohr DW; Bettinotti M; Shomron N; Avery RK; Arav-Boger R
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of spontaneous CMV DNAemia clearance in kidney transplantation.
    Noble J; Gatault P; Sautenet B; Gaudy-Graffin C; Beby-Defaux A; Thierry A; Essig M; Halimi JM; Munteanu E; Alain S; Buchler M
    J Clin Virol; 2018; 99-100():38-43. PubMed ID: 29306112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
    Solano C; Giménez E; Piñana JL; Albert E; Vinuesa V; Hernández-Boluda JC; Amat P; Navarro D
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28471073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients.
    Aryal S; Katugaha SB; Cochrane A; Brown AW; Nathan SD; Shlobin OA; Ahmad K; Marinak L; Chun J; Fregoso M; Desai S; King C
    Transpl Infect Dis; 2019 Dec; 21(6):e13166. PubMed ID: 31487755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
    Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of progression and clearance of low-level CMV DNAemia in solid organ transplant recipients.
    Natori Y; Alghamdi A; Husain S; Rotstein C; Selzner N; Tikkanen J; Schiff J; Humar A; Kumar D
    Transpl Infect Dis; 2020 Feb; 22(1):e13207. PubMed ID: 31677321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    Lee H; Park KH; Ryu JH; Choi AR; Yu JH; Lim J; Han K; Kim SI; Yang CW; Chung BH; Oh EJ
    PLoS One; 2017; 12(12):e0189488. PubMed ID: 29232714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation.
    Reischig T; Kacer M; Hruba P; Jindra P; Hes O; Lysak D; Bouda M; Viklicky O
    Antivir Ther; 2017; 22(6):503-513. PubMed ID: 28091392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients.
    Beechar VB; Phadke VK; Pouch SM; Mehta AK; Karadkhele G; Larsen CP; Woodworth MH
    Clin Transplant; 2024 Oct; 38(10):e15480. PubMed ID: 39427300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients.
    Beechar VB; Pouch SM; Phadke VK; Karadkhele G; Larsen CP; Woodworth MH
    Transpl Infect Dis; 2024 Feb; 26(1):e14219. PubMed ID: 38158932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
    Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
    J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.